Literature DB >> 7637715

Toxoplasma gondii tachyzoites possess an unusual plasma membrane adenosine transporter.

J C Schwab1, M Afifi Afifi, G Pizzorno, R E Handschumacher, K A Joiner.   

Abstract

Nucleoside transport may play a critical role in successful intracellular parasitism by Toxoplasma gondii. This protozoan is incapable of de novo purine synthesis, and must salvage purines from the host cell. We characterized purine transport by extracellular T. gondii tachyzoites, focusing on adenosine, the preferred salvage substrate. Although wild-type RH tachyzoites concentrated [3H]adenosine 1.8-fold within 30 s, approx. half of the [3H]adenosine was converted to nucleotide, consistent with the known high parasite adenosine kinase activity. Studies using an adenosine kinase deficient mutant confirmed that adenosine transport was non-concentrative. [14C]Inosine, [14C]hypoxanthine and [3H]adenine transport was also rapid and non-concentrative. Adenosine transport was inhibited by dipyridamole (IC50 approx. 0.7 microM), but not nitrobenzylthioinosine (15 microM). Transport of inosine, hypoxanthine and adenine was minimally inhibited by 10 microM dipyridamole, however. Competition experiments using unlabeled nucleosides and bases demonstrated distinct inhibitor profiles for [3H]adenosine and [14C]inosine transport. These results are most consistent with a single, dipyridamole-sensitive, adenosine transporter located in the T. gondii plasma membrane. Additional permeation pathways for inosine, hypoxanthine, adenine and other purines may also be present.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637715     DOI: 10.1016/0166-6851(95)00005-l

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

1.  Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology.

Authors:  J A Silverman; M L Hayes; B J Luft; K A Joiner
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

Review 2.  Targeting purine and pyrimidine metabolism in human apicomplexan parasites.

Authors:  John E Hyde
Journal:  Curr Drug Targets       Date:  2007-01       Impact factor: 3.465

3.  Inhibition and structure of Toxoplasma gondii purine nucleoside phosphorylase.

Authors:  Teraya M Donaldson; María B Cassera; Meng-Chiao Ho; Chenyang Zhan; Emilio F Merino; Gary B Evans; Peter C Tyler; Steven C Almo; Vern L Schramm; Kami Kim
Journal:  Eukaryot Cell       Date:  2014-02-28

4.  Uptake of nitrobenzylthioinosine and purine beta-L-nucleosides by intracellular Toxoplasma gondii.

Authors:  Omar N Al Safarjalani; Fardos N M Naguib; Mahmoud H El Kouni
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

5.  CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system.

Authors:  Deeqa A Mahamed; Jeffrey H Mills; Charlotte E Egan; Eric Y Denkers; Margaret S Bynoe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

6.  A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.

Authors:  Lisa Sharling; Xiaoping Liu; Deviprasad R Gollapalli; Sushil K Maurya; Lizbeth Hedstrom; Boris Striepen
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

7.  Cationic amino acid transporters play key roles in the survival and transmission of apicomplexan parasites.

Authors:  Esther Rajendran; Sanduni V Hapuarachchi; Catherine M Miller; Stephen J Fairweather; Yeping Cai; Nicholas C Smith; Ian A Cockburn; Stefan Bröer; Kiaran Kirk; Giel G van Dooren
Journal:  Nat Commun       Date:  2017-02-16       Impact factor: 14.919

8.  A Toxoplasma gondii Oxopurine Transporter Binds Nucleobases and Nucleosides Using Different Binding Modes.

Authors:  Gustavo D Campagnaro; Hamza A A Elati; Sofia Balaska; Maria Esther Martin Abril; Manal J Natto; Fabian Hulpia; Kelly Lee; Lilach Sheiner; Serge Van Calenbergh; Harry P de Koning
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.